Skip to content

Programs
Client Portfolio
Services
- Access to Funding
- Venture Advisory Services
About
Contact
Media

Menu

Programs
Client Portfolio
Services
- Access to Funding
- Venture Advisory Services
About
Contact
Media

Novartis

Loading...

Default Featured Image

News

Sickle cell disease treatment has roots in lab of OMRF’s Dr. Rodger McEver

Default Featured Image

News

Prescott: A homegrown biotech success story

Default Featured Image

News

Humble beginnings at Moore gas station launched career of Selexys CEO Scott Rollins

Default Featured Image

News

Oklahoma City Finds a Sweet Spot on America’s ‘Silicon Prairie’

Default Featured Image

News

Selexys a local success story for entrepreneurship

Default Featured Image

News

OKC pharma firm acquired in deal valued up to $665 million

Default Featured Image

News

i2E portfolio company announces exit

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

Client Portfolio
About Us
Media
Events
Contact
Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

E3
ACT Tulsa
Love's Entrepreneur's Cup
OKBio

Client Portfolio

Services

Access to Funding
Venture Advisory Services

Contact

About

Our Values
Our Team
Board of Directors
Corporate Partners

Media